Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
St. Petersburg State Pavlov Medical University
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
University of Rochester
University Health Network, Toronto
Astex Pharmaceuticals, Inc.
OHSU Knight Cancer Institute
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute
CTI BioPharma
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Alliance for Clinical Trials in Oncology
University of Wisconsin, Madison
Vanderbilt-Ingram Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Texas Southwestern Medical Center
City of Hope Medical Center
St. Petersburg State Pavlov Medical University
Barbara Ann Karmanos Cancer Institute
University of Washington
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Children's Oncology Group